Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:
- an article about the Biden Administration advising the Supreme Court not to review a pharmaceutical patent decision raising questions related to the enablement requirement;
- a second article about the United States Patent and Trademark Office Director Kathi Vidal’s response “to a number of questions surrounding abuse of the inter partes review . . . system”; and
- a third article about “[a] recent district court order punt[ing] concerns about an administrative patent tribunal’s alleged bias to the Federal Circuit.”